Ades Felipe, Tryfonidis Konstantinos, Zardavas Dimitrios
Hospital Albert Einstein, Avenida Albert Einstein, 627 - Morumbi, São Paulo - SP, 05652-900 Brazil.
European Organisation for Research and Treatment of Cancer, Avenue E. Mounier 83/11, 1200 Brussels, Belgium.
Ecancermedicalscience. 2017 Jun 8;11:746. doi: 10.3332/ecancer.2017.746. eCollection 2017.
Cancer is one of the oldest diseases ever described, since ancient Egypt there have always been attempts to treat and cure this illness. The growing body of knowledge about breast cancer biology and improvements in surgical and medical treatments has been built over time with contributions from many talented and enthusiastic physicians and researchers. Medical advances have changed the approach from a previously incurable condition, into a surgical disease. Further improvements in cancer biology have allowed the development of systemic treatments, hormonal therapies, and targeted drugs. The description of the molecular intrinsic subtypes of breast cancer clarified the understanding of breast cancer as a group of heterogeneous diseases, associated with different clinical outcomes, and therapeutic opportunities. This paper reviews how breast cancer treatment has improved since the earliest descriptions, in ancient times, and how future approaches, such as gene signatures, molecular profiling, and liquid biopsies, aim to further develop individualised treatments and improve treatment outcomes.
癌症是有史以来最古老的疾病之一,自古埃及以来,人们就一直在尝试治疗和治愈这种疾病。随着时间的推移,众多才华横溢、满腔热忱的医生和研究人员不断贡献力量,有关乳腺癌生物学的知识日益丰富,手术和医学治疗也不断进步。医学进展已将乳腺癌的治疗方式从以前的不治之症转变为一种可通过手术治疗的疾病。癌症生物学的进一步发展催生了全身治疗、激素疗法和靶向药物。乳腺癌分子内在亚型的描述,使人们对乳腺癌作为一组具有不同临床结局和治疗机会的异质性疾病有了更清晰的认识。本文回顾了自古代最早描述以来乳腺癌治疗取得的进展,以及诸如基因特征、分子图谱和液体活检等未来方法如何旨在进一步发展个性化治疗并改善治疗效果。